NRP1 and cancer: In such targeted anti-angiogenic radionuclide treatment, diagnostic and therapeutic radiocompounds designed in this work would enable both the real-time localization of cancer cells at the molecular level at a very early stage of tumor development by imaging the pathological VEGF-A165/NRP-1-related vascular system in its close microenvironment, as well as the selective inhibition of the formation of pathological vascularization and the destruction of previously located tumor cells.